We are live on
!
Find out more
Handelsbanken Fonder Portfolio holdings
AUM
$35.1B
1-Year Est. Return
47.76%
This Fund
S&P 500
This Quarter
Est. Return
+5.31%
1 Year Est. Return
+47.76%
3 Year Est. Return
+137.96%
5 Year Est. Return
+170.36%
10 Year Est. Return
+934.7%
AUM
$23B
AUM Growth
-$233M
(-1%)
Cap. Flow
-$880M
Cap. Flow
% of AUM
-3.82%
Top 10 Holdings %
Top 10 Hldgs %
33.31%
Holding
1,606
New
44
Increased
614
Reduced
449
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$63.2M |
| 2 |
Eagle Materials
EXP
|
+$56.2M |
| 3 |
Itron
ITRI
|
+$54.4M |
| 4 |
Apple
AAPL
|
+$52.6M |
| 5 |
Enphase Energy
ENPH
|
+$40.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cooper Companies
COO
|
+$82.8M |
| 2 |
NVIDIA
NVDA
|
+$76M |
| 3 |
Microsoft
MSFT
|
+$62.6M |
| 4 |
Adobe
ADBE
|
+$62.2M |
| 5 |
Jabil
JBL
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 36.79% |
| 2 | Healthcare | 19.28% |
| 3 | Financials | 10.14% |
| 4 | Communication Services | 9.05% |
| 5 | Industrials | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
McGrath RentCorp
MGRC
$2.94B
| $454K | ﹤0.01% |
4,258
| – | – |
|
1202
MoonLake Immunotherapeutics
MLTX
$1.4B
| $453K | ﹤0.01% |
+10,300
| New | +$436K |
|
1203
Riot Platforms
RIOT
$7.21B
| $453K | ﹤0.01% |
49,600
+19,500
| +65% | +$197K |
|
1204
Brady Corp
BRC
$4.43B
| $450K | ﹤0.01% |
6,809
-2,700
| -28% | -$169K |
|
|
CPRX
1205
DELISTED
Catalyst Pharmaceutical
CPRX
| $449K | ﹤0.01% |
28,977
+3,700
| +15% | +$57.6K |
|
1206
Independent Bank
INDB
$4.05B
| $448K | ﹤0.01% |
8,829
-700
| -7% | -$35K |
|
1207
Arvinas
ARVN
$589M
| $443K | ﹤0.01% |
16,625
-2,500
| -13% | -$79.7K |
|
|
BWIN
1208
Baldwin Insurance Group
BWIN
$2.99B
| $443K | ﹤0.01% |
12,500
| – | – |
|
1209
WaFd
WAFD
$2.81B
| $442K | ﹤0.01% |
15,474
| – | – |
|
1210
Cohu
COHU
$2.76B
| $440K | ﹤0.01% |
13,300
| – | – |
|
1211
HNI Corp
HNI
$3.56B
| $438K | ﹤0.01% |
9,726
| – | – |
|
1212
QuantumScape Corp
QS
$3.79B
| $438K | ﹤0.01% |
89,000
+5,000
| +6% | +$27.9K |
|
1213
Global Net Lease
GNL
$1.9B
| $437K | ﹤0.01% |
59,446
+21,000
| +55% | +$152K |
|
|
HTO
1214
H2O America
HTO
$2.65B
| $437K | ﹤0.01% |
8,065
+29
| +0.4% | +$1.59K |
|
1215
Galicia Financial Group
GGAL
$7.23B
| $433K | ﹤0.01% |
+14,165
| New | +$455K |
|
1216
Bank of Hawaii
BOH
$3.15B
| $431K | ﹤0.01% |
7,537
-700
| -8% | -$40.6K |
|
|
THS
1217
DELISTED
Treehouse Foods
THS
| $429K | ﹤0.01% |
11,709
-2,100
| -15% | -$76.1K |
|
1218
Intercorp Financial Services
IFS
$6.04B
| $428K | ﹤0.01% |
19,100
-164,900
| -90% | -$3.72M |
|
1219
Immunovant
IMVT
$8.64B
| $428K | ﹤0.01% |
16,200
+4,400
| +37% | +$125K |
|
1220
Sonos
SONO
$1.96B
| $428K | ﹤0.01% |
29,000
| – | – |
|
1221
Criteo S.A. Ordinary Shares
CRTO
$915M
| $426K | ﹤0.01% |
11,300
-400
| -3% | -$14.6K |
|
1222
First Financial Bancorp
FFBC
$3.6B
| $426K | ﹤0.01% |
19,184
+3,300
| +21% | +$72.9K |
|
1223
Marqeta
MQ
$1.71B
| $426K | ﹤0.01% |
19,450
+1,075
| +6% | +$23.7K |
|
|
MORF
1224
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $426K | ﹤0.01% |
12,500
+1,000
| +9% | +$29.6K |
|
|
INFA
1225
DELISTED
Informatica
INFA
| $425K | ﹤0.01% |
13,764
-4,100
| -23% | -$129K |
|
Similar funds
GAM
Handelsbanken Fonder's Q2 2024 Portfolio in Review
As of Q2 2024, Handelsbanken Fonder held 1,606 positions worth $23B, down 1% from $23.2B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Handelsbanken Fonder withdrew a net $880M in Q2 2024, closing 86 positions and reducing 449 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $20.6M position sold in full.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 33% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Handelsbanken Fonder opened a new position in Kenvue worth $12.8M.
- Handelsbanken Fonder's largest Q2 2024 buy was Kenvue: 701,911 shares worth $12.8M.
- Handelsbanken Fonder added most to Vertex Pharmaceuticals in Q2 2024, an estimated $63.2M increase.
- Handelsbanken Fonder's biggest Q2 2024 reduction was Cooper Companies, cutting an estimated $82.8M.
- Handelsbanken Fonder fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $20.6M.
- Handelsbanken Fonder's ten largest holdings make up 33% of its $23B portfolio in Q2 2024.
- Handelsbanken Fonder opened 44 new positions and closed 86 in Q2 2024.
- Handelsbanken Fonder's portfolio value fell 1% quarter-over-quarter to $23B.
Based on Handelsbanken Fonder's 13F filing for Q2 2024, filed 5 Aug 2024.